Alopecia universalis secondary to adalimumab treatment for psoriasis in a child

Dermatol Ther. 2020 Nov;33(6):e14090. doi: 10.1111/dth.14090. Epub 2020 Aug 14.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adalimumab / adverse effects
  • Alopecia* / chemically induced
  • Alopecia* / diagnosis
  • Alopecia* / drug therapy
  • Child
  • Humans
  • Psoriasis* / chemically induced
  • Psoriasis* / diagnosis
  • Psoriasis* / drug therapy

Substances

  • Adalimumab

Supplementary concepts

  • Alopecia universalis